-
公开(公告)号:US4906669A
公开(公告)日:1990-03-06
申请号:US234895
申请日:1988-08-22
IPC分类号: A61K31/015 , A61K31/047 , A61K31/05 , A61K31/085 , A61K31/09 , A61K31/12 , A61K31/122 , A61K31/215 , A61K31/22 , A61K31/35 , A61K31/352 , A61K31/355 , A61P1/04 , C07C1/00 , C07C15/107 , C07C15/44 , C07C39/06 , C07C39/08 , C07C39/10 , C07C39/19 , C07C41/00 , C07C43/205 , C07C43/215 , C07C45/00 , C07C50/06 , C07C67/00 , C07C69/035 , C07C69/157 , C07C69/16 , C07C69/18 , C07C69/95 , C07C401/00 , C07C403/02 , C07D311/58 , C07D311/64 , C07D311/72
CPC分类号: C07C43/215 , A61K31/05 , A61K31/085 , A61K31/09 , A61K31/12 , A61K31/22 , A61K31/355 , C07C39/19 , C07C50/06 , C07D311/58 , C07D311/72
摘要: Anti-ulcer agents containing isoprenoid derivatives are provided. The isoprenoid derivatives are represented by the formula: ##STR1## wherein: R represents a group of formula ##STR2## In the above formula, R.sub.1, R.sub.2 and R.sub.3 may be the same or different each other and each represents a hydrogen atom, a hydroxy group, a lower alkanoyloxy group, a lower alkyl group or a lower alkoxy group, provided that two or more of them do not represent hydrogen atoms at the same time; R.sub.4 and R.sub.5 may be the same or different each other and each represents a hydrogen atom, a hydroxy group or a lower alkanoyloxy group represents the signal or the double bond between the carbon atoms; m represents 0 or 1; n represents 0 or an integer of from 1 to 9, provided that the sum of m and n is an integer of from 1 to 9.
-
公开(公告)号:US4526893A
公开(公告)日:1985-07-02
申请号:US562237
申请日:1983-12-16
申请人: Toshihiro Takahashi , Noriyoshi Sueda , Masahiro Tsuji , Yoshiyuki Tahara , Hiroyasu Koyama , Yoshikuni Suzuki , Masao Nagase , Toshiji Sugai
发明人: Toshihiro Takahashi , Noriyoshi Sueda , Masahiro Tsuji , Yoshiyuki Tahara , Hiroyasu Koyama , Yoshikuni Suzuki , Masao Nagase , Toshiji Sugai
IPC分类号: A61K31/47 , A61K31/472 , A61P9/06 , A61P9/08 , A61P9/10 , A61P9/12 , A61P25/02 , A61P27/02 , A61P27/06 , C07D217/24
CPC分类号: C07D217/24
摘要: Compounds of the structure ##STR1## wherein X, R.sub.1, R.sub.2, R.sub.3, R.sub.4, and R.sub.5 are as herein defined, effective as .beta.-blockers and hypotensive agents, are described.
摘要翻译: 描述了作为β-阻断剂和降压药有效的结构
的化合物,其中X,R 1,R 2,R 3,R 4和R 5如本文所定义。 -
公开(公告)号:US4265910A
公开(公告)日:1981-05-05
申请号:US145754
申请日:1980-05-01
CPC分类号: A61K31/13
摘要: This invention relates to new isoprenylamines and the acid addition salts thereof. Further, the invention is concerned with antiviral agents for vertebrate animal, said agents containing as their active ingredients isoprenylamine or physiologically acceptable acid addition salt thereof.
摘要翻译: 本发明涉及新的异戊二烯胺及其酸加成盐。 此外,本发明涉及用于脊椎动物的抗病毒剂,所述药物含有作为其活性成分的异戊二胺或其生理上可接受的酸加成盐。
-
公开(公告)号:US6048882A
公开(公告)日:2000-04-11
申请号:US875759
申请日:1997-08-08
申请人: Tatsuya Ohwaki , Masako Yamada , Hiroyuki Yamazaki , Hitoshi Inoue , Yoshiyuki Tahara , Shigeo Kawase
发明人: Tatsuya Ohwaki , Masako Yamada , Hiroyuki Yamazaki , Hitoshi Inoue , Yoshiyuki Tahara , Shigeo Kawase
IPC分类号: C07C211/27 , C07C211/29 , C07C215/50 , C07C217/58 , C07D213/38 , C07D307/52 , C07D317/58 , C07D317/66 , C07D333/20 , A61K31/34 , A61K31/36
CPC分类号: C07D213/38 , C07C211/27 , C07C211/29 , C07C215/50 , C07C217/58 , C07D307/52 , C07D317/58 , C07D317/66 , C07D333/20
摘要: Hepatic diseases can be prevented or treated by administering an isoprenylamine derivative represented by the general formula (II) ##STR1## [wherein n represents an integer of 4-12, m represents an integer of 0-3, Ar represents a phenyl group, a furyl group, a thienyl group or a pyridyl group, said group being optionally substituted with one or more of an alkyl group of 1-4 carbon atoms, and alkoxy group of 1-4 carbon atoms, a methylenedioxy group, a hydroxy group or a halogen atom, and R represents a hydrogen atom or an alkyl group of 1-4 carbon atoms] or a pharmacologically acceptable salt thereof at a daily dose of 0.01-500 .mu.g/kg.A lipid emulsion of the compound (II) is particularly useful and can be administered at a remarkably lowered dose as compared with other pharmaceutical preparations.
摘要翻译: PCT No.PCT / JP96 / 00255 Sec。 371日期:1997年8月8日 102(e)日期1997年8月8日PCT提交1996年2月7日PCT公布。 出版物WO96 / 24575 日期:1996年8月15日可以通过施用通式(II)表示的异戊二烯胺衍生物[其中n表示4-12的整数,m表示0-3的整数,Ar表示苯基 ,呋喃基,噻吩基或吡啶基,所述基团任选被一个或多个1-4个碳原子的烷基和1-4个碳原子的烷氧基,亚甲二氧基,羟基 或卤素原子,R表示氢原子或1-4个碳原子的烷基]或其药理学上可接受的盐,日剂量为0.01-500μg/ kg。 化合物(II)的脂质乳剂特别有用,与其它药物制剂相比,可以以显着降低的剂量给药。
-
公开(公告)号:US5116855A
公开(公告)日:1992-05-26
申请号:US521902
申请日:1990-05-11
IPC分类号: C07D277/36 , C07D417/06 , C07D417/12
CPC分类号: C07D417/06 , C07D277/36 , C07D417/12
摘要: Disclosed is a rhodanine derivative of formula (I).A rhodanine derivative of formula (I) ##STR1## wherein R.sup.1 is hdyrogen, C.sub.1 -C.sub.8 alkyl, carboxyl(C.sub.1 -C.sub.4)alkyl or (C.sub.1 -C.sub.4)alkoxycarbonyl(C.sub.1 -C.sub.4)alkyl;R.sup.2 is --CH.sub.2 --CH.sub.2 --R.sup.3, CH.dbd.CH.sub.m R.sup.3 (m is 0 or 1), ##STR2## (R is C.sub.1 -C.sub.3 alkyl) or --CH.sub.2n CONHR.sup.4 (n is 0 or 1-4); R.sup.3 is a thienyl or furyl group which may be substituted by C.sub.1 -C.sub.3 alkyl or halogen; a pyrrolyl group which may be substituted by carboxy(C.sub.1 -C.sub.3)alkyl on the nitrogen atom; or a phenyl group which may be substituted by one or more substituents selected from the group consisting of C.sub.1 -C.sub.3 alkyl, C.sub.1 -C.sub.3 alkoxy, hydroxyl, halogen, trifluoromethyl, carboxyl, (C.sub.1 -C.sub.3)alkoxycarbonyl, cyano, carboxy(C.sub.1 -C.sub.3)alkoxy, (C.sub.1 -C.sub.6)alkoxycarbonyl(C.sub.1 -C.sub.3)alkoxy, benzyloxycarbonyl(C.sub.1 -C.sub.3)alkoxy, piperidinylcarbonyl(C.sub.1 -C.sub.3)alkoxy, 2H-tetrazolyl, 2H-tetrazolyl-(C.sub.1 -C.sub.4)alkoxy, carboxy(C.sub.2 -C.sub.4)alkenyl, (C.sub.1 -C.sub.3)alkoxycarbonyl(C.sub.2 -C.sub.4)alkenyl, carboxy(C.sub.1 -C.sub.3)alkyl and (C.sub.1 -C.sub.3)alkoxycarbonyl(C.sub.1 -C.sub.3)alkyl; andR.sup.4 is a phenyl group which may be substituted by one or more of the same substituents as defined above, or a pharmaceutically acceptable salt thereof.The derivatives are of an inhibitory activity against aldose reductase and useful for the prevention or treatment of complications of diabetes.
-
公开(公告)号:US5004735A
公开(公告)日:1991-04-02
申请号:US373909
申请日:1989-06-29
IPC分类号: A61K31/045 , A61K31/66 , A61K31/745 , A61K31/765 , A61K31/80 , A61P31/04 , A61P35/00 , A61P43/00 , C07C33/02 , C07F9/113 , C08F36/08
CPC分类号: A61K31/66 , A61K31/045 , Y10S514/937
摘要: Polyprenols and polyprenyl phosphates are of the formula ##STR1## wherein ##STR2## represents a trans-isoprene unit, ##STR3## represents a cis-isoprene unit, ##STR4## represents a dihydroisoprene unit, l is an integer of 2 to 8, m is 0 or an integer of 5 to 18, n is 0 or 1, the sum of l and m is in the range of 8 to 20, and X represents a hydrogen atom or --PO.sub.3 MM' wherein M and M' may be the same or different and each is a hydrogen atom or a monovalent cation or both M and M' together form a divalent cation. They are useful as a medicament for the inhibition of tumor metastasis.
-
公开(公告)号:US4645862A
公开(公告)日:1987-02-24
申请号:US723082
申请日:1985-04-15
申请人: Yoshiyuki Tahara , Yasuhiro Komatsu , Hiroyasu Koyama , Reiko Kubota , Teruhito Yamaguchi , Toshihiro Takahashi
发明人: Yoshiyuki Tahara , Yasuhiro Komatsu , Hiroyasu Koyama , Reiko Kubota , Teruhito Yamaguchi , Toshihiro Takahashi
IPC分类号: C07D295/12 , A61K31/13 , A61K31/135 , A61P31/12 , C07C67/00 , C07C209/00 , C07C211/09 , C07C211/21 , C07C211/27 , C07C211/44 , C07C213/00 , C07C215/02 , C07C215/10 , C07C215/14 , C07C215/30 , C07C217/56 , C07C217/58 , C07C217/60 , C07C217/62 , C07D273/08 , C07D295/13 , C07C87/28 , C07C87/48
CPC分类号: C07D295/13
摘要: Compounds of the formula ##STR1## wherein R.sub.1 and R.sub.3 each is benzyl or substituted with up to 3 methoxy groups, R.sub.2 is a hydrogen atom and (alkylene) is lower alkyl and the compounds are useful for controlling viral infections.
摘要翻译: 其中R 1和R 3各自为苄基或被至多3个甲氧基取代的式的化合物,R 2为氢原子,(亚烷基)为低级烷基,并且该化合物可用于控制病毒感染。
-
公开(公告)号:US4380668A
公开(公告)日:1983-04-19
申请号:US208324
申请日:1980-11-19
IPC分类号: C07D213/38 , C07D213/74 , C07C87/28 , A61K31/13 , A61K31/44 , C07D213/06
CPC分类号: C07D213/74 , C07D213/38 , Y10S514/889
摘要: This invention relates to new decaprenylamines and the acid addition salts thereof, which are useful for controlling virus infection of vertebrate animals.
摘要翻译: 本发明涉及用于控制脊椎动物病毒感染的新癸酰胺及其酸加成盐。
-
公开(公告)号:US4221810A
公开(公告)日:1980-09-09
申请号:US889568
申请日:1978-03-23
IPC分类号: C07C51/38 , C07D311/72 , A61K31/355
CPC分类号: C07D311/72 , C07C51/38 , Y10S514/925
摘要: .alpha.-Tocopheryl derivatives, useful as agents for the treatment of ulcer, are described.
摘要翻译: 描述了可用作治疗溃疡的药物的α-生育酚衍生物。
-
公开(公告)号:US5182267A
公开(公告)日:1993-01-26
申请号:US626302
申请日:1990-12-12
申请人: Osamu Ogawa , Ikuo Kishi , Yoshiyuki Tahara , Masanori Sugita
发明人: Osamu Ogawa , Ikuo Kishi , Yoshiyuki Tahara , Masanori Sugita
IPC分类号: A61K9/107 , A61K31/135
CPC分类号: A61K9/1075 , A61K31/135
摘要: A pharmaceutical oil-in-water type microemulsion having an action of potentiating the activities of anti-cancer agents, said micro-emulsion comprisesfine particles of a vegetable oil or a triglyceride of a medium-chain fatty acid having 8 to 12 carbon atoms containing 0.1 to 10% (w/v) of N-solanesyl-N,N'-bis(3,4-dimethoxybenzyl)ethylenediamine malate of formula (I) below, ##STR1## an aqueous medium, and 0.05 to 25% (w/v) of a physiologically acceptable phospholipid for dispersing said fine particles in said aqueous medium.
摘要翻译: 具有增强抗癌剂活性的作用的药用油包水型微乳液,所述微乳液包含具有8至12个碳原子的中链脂肪酸的植物油或甘油三酸酯的细颗粒,其含有 0.1至10%(w / v)下式(I)的N-茄酰基-N,N'-双(3,4-二甲氧基苄基)乙二胺苹果酸盐,水性介质,和 用于将所述细颗粒分散在所述水性介质中的生理学上可接受的磷脂的0.05至25%(w / v)。
-
-
-
-
-
-
-
-
-